Specialty Pharmacy

Anti-PDL1 agent with standard chemotherapy combination will now move to multiple phase 3 studies.

Marc O'Connor, Chief Operating Officer of Curant Health, discusses the main takeaways from the impact of hepatitis C drugs on specialty pharmacy.

Agreement ensures MHA members better access to Mediware's homecare software solutions.

The FDA today amended its breakthrough therapy designation for an experimental hepatitis C drug combination.

Recent changes to reimbursement algorithms create new opportunities for consultant pharmacists to strengthen their contributions to managed care contracts.

Study finds benefits from reduced absenteeism and improved workplace productivity.

Height can impact wait times for transplantation and overall mortality.

More health-systems are opening on-site retail pharmacies to improve medication adherence and patient care after discharge and reduce costly hospital readmissions.

Technology that can safely dispose of unused prescription medications is now available directly to consumers online.

In patients at risk for type 2 diabetes, diet and exercise have beneficial effects on regulating glucose levels beyond those associated with weight loss.

Bacterial enzyme could offer new target for treatment of condition.

Economic downturn associated with cancer mortality.

A class of type 2 diabetes drugs could lead to a serious complication that might require hospitalization.

Blood test predicts which patients will respond to interferon.

Top stories of the week on Specialty Pharmacy Times from May 11 to May 15.

Drugs that activate nervous system stem cells may cause formation of new myelin.

Infant antibiotic use may be linked with disease later in life.

Link found between new onset obstructive sleep apnea and habitual sleepiness.

Black men more likely to be diagnosed with breast cancer at a younger age than white men.

Study may add to the ability to predict RA outcomes.

Collaboration creates industry-leading alliance providing pharmacy consulting, talent acquisition, legal and accounting services to the rapidly growing specialty pharmacy industry.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the impact of the Affordable Care Act on specialty pharmacy.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the significance of the annual Armada Specialty Pharmacy Summit.

Excess medical expenses, employment disability, and a drop in production at work common in cancer survivors.

Promising results from generic formulation of drug used post-transplant to reduce the risk of organ rejection.

Study warns that drug reviewers don't look at long term survival of patients.

Investigational 3-drug combination cleared the virus in 93% of treatment-naïve patients.

Particles protected antigen from premature destruction and prompted the immune system to attack cancer cells.

The FDA is actively investigating vulnerabilities identified in Hospira's LifeCare PCA3 and PCA5 infusion pump systems.

Direct-acting-antiviral drugs daclatasvir, asunaprevir, and beclabuvir showed high rates of sustained virologic response after 12 weeks.